Sorafenib Continuation after First Disease Progression Could Reduce Disease Flares and Provide Survival Benefits in Patients with Hepatocellular Carcinoma: a Pilot Retrospective Study
-
- Asian Pacific Journal of Cancer Prevention
- /
- v.15 no.7
- /
- pp.3151-3156
- /
- 2014